Epoch Life Science provides molecular biology products and custom laboratory services for researchers and life science professionals. Their offerings include nucleic acid purification kits, DNA cloning kits, sequencing consumables, enzymes, and custom services such as gene synthesis, mutagenesis, and DNA sequencing.
Subscribe to see EPOCH Epigenetics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EPOCH Epigenetics, Inc. is a biotechnology company headquartered in Baltimore, United States. Its most recent funding round raised $72,500 in February 2025. Xcout tracks 4 named people at EPOCH Epigenetics, Inc., including Joseph Swiader (Chief Executive Officer).
As of 20 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $72,500 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of EPOCH Epigenetics, Inc.'s closest competitors — see the full list of competitors and alternatives →
New England Biolabs (NEB) is a certified B Corporation that supplies reagents for the life sciences industry. Headquartered on a 160-acre campus in Ipswich, Massachusetts, the company provides vital research products while maintaining a strong commitment to environmental and campus sustainability.
Integrated DNA Technologies manufactures and supplies custom nucleic acid products, including DNA and RNA oligonucleotides, qPCR assays, CRISPR genome editing tools, gene fragments, and next-generation sequencing reagents. The company serves researchers and life science professionals in academic, clinical, and industrial sectors.
Nuclera provides products and services for multiplex protein screening and expression, including the eProtein Discovery system and related reagents, software, and services. The company serves researchers and scientists in drug discovery and biotechnology by enabling them to perform in-house protein design, screening, characterization, and small-scale expression.
DINYA DNA is a biotechnology company headquartered in Durham, United States, that builds next-generation DNA synthesis technology using a novel enzymatic platform to produce long double-stranded DNA.
AffiGEN Holdings LLC supplies life science reagents and molecular biology products, including antibodies, ELISA kits, recombinant proteins, and PCR controls. The company serves laboratories and researchers worldwide to support biological research and molecular assay development.
National Diagnostics, Inc. manufactures and supplies chemicals, reagents, and laboratory products for life sciences research. The company provides materials for electrophoresis, histology, liquid scintillation counting, and oxygen assays to support laboratory experiments and innovations.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about EPOCH Epigenetics, Inc.? Suggest a correction · Work at EPOCH Epigenetics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.